Search research articles
Contact Us
Filters
Showing results (61-70 of 150) with videos related to
Page
of 15
Sort By:
Seminars in Oncology
|
April 4, 2001
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials
F A Shepherd, F V Fossella, T Lynch, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
December 16, 1982
[Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone]
J Chauvergne, N B Bui, P Cappelaere, et al.
American Journal of Clinical Oncology
|
October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma
E Tellez-Bernal, M Belehradek, G Recondo, et al.
Journal of Chromatography
|
March 27, 1992
Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients
I Barilero, D Gandia, J P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 3, 2003
Nasopharyngeal carcinomas: an update
J-P Spano, P Busson, D Atlan, et al.
International Journal of Cancer
|
May 4, 1995
Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern Asia
F Chakrani, J P Armand, G Lenoir, et al.
Journal of Neuro-Oncology
|
January 1, 1993
Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas
F B Cvitkovic, C Haie-Meder, V Papadimitrakopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours
J Bennouna, P Fumoleau, J-P Armand, et al.
La Nouvelle Presse Medicale
|
February 14, 1976
[The half-life of iodine 131-labelled fibrinogen in cancer patients. Effects of heparin]
A Boneu, J P Armand, A Blasco, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
New approach to metabolism of 5'-deoxy-5-fluorouridine in humans with fluorine-19 NMR
M C Malet-Martino, R Martino, A Lopez, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 150) with videos related to
Sort By:
Page
of 15
Seminars in Oncology
|
April 4, 2001
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials
F A Shepherd, F V Fossella, T Lynch, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
December 16, 1982
[Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone]
J Chauvergne, N B Bui, P Cappelaere, et al.
American Journal of Clinical Oncology
|
October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma
E Tellez-Bernal, M Belehradek, G Recondo, et al.
Journal of Chromatography
|
March 27, 1992
Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients
I Barilero, D Gandia, J P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 3, 2003
Nasopharyngeal carcinomas: an update
J-P Spano, P Busson, D Atlan, et al.
International Journal of Cancer
|
May 4, 1995
Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern Asia
F Chakrani, J P Armand, G Lenoir, et al.
Journal of Neuro-Oncology
|
January 1, 1993
Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas
F B Cvitkovic, C Haie-Meder, V Papadimitrakopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours
J Bennouna, P Fumoleau, J-P Armand, et al.
La Nouvelle Presse Medicale
|
February 14, 1976
[The half-life of iodine 131-labelled fibrinogen in cancer patients. Effects of heparin]
A Boneu, J P Armand, A Blasco, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
New approach to metabolism of 5'-deoxy-5-fluorouridine in humans with fluorine-19 NMR
M C Malet-Martino, R Martino, A Lopez, et al.
Page
of 15